ready Cancer Drug Interactions

General Information
Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

Awaiting DOI assignment.

Record added: April 21, 2020, 11:52 a.m.
Record updated: Feb. 23, 2021, 11:04 a.m. by The FAIRsharing Team.

Show edit history



Additional Information

Access / Retrieve Data

Conditions of Use

Applies to: Data use

Data Access


No publications available

Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

No semantic standards defined

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined


No metrics standards defined

Related Databases

No related databases defined

Implementing Policies

This record is not implemented by any policy.


Record Maintainer

  • This record is in need of a maintainer. If you login, you'll be able to claim this record.